Search Results - "Sharma, Pawana"

Refine Results
  1. 1

    Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis by Ma, Chenhan, Avenell, Alison, Bolland, Mark, Hudson, Jemma, Stewart, Fiona, Robertson, Clare, Sharma, Pawana, Fraser, Cynthia, MacLennan, Graeme

    Published in BMJ (Online) (14-11-2017)
    “…Objective To assess whether weight loss interventions for adults with obesity affect all cause, cardiovascular, and cancer mortality, cardiovascular disease,…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Measuring the population burden of chronic kidney disease: a systematic literature review of the estimated prevalence of impaired kidney function by MCCULLOUPH, Keith, SHARMA, Pawana, ALI, Tariq, KHAN, Izhar, SMITH, William C. S, MACLEOD, Alison, BLACK, Corri

    Published in Nephrology, dialysis, transplantation (01-05-2012)
    “…Internationally, there have been substantial efforts to improve the early identification of chronic kidney disease (CKD), with a view to improving survival,…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Diagnostic Models Combining Clinical Information, Ultrasound and Biochemical Markers for Ovarian Cancer: Cochrane Systematic Review and Meta-Analysis by Davenport, Clare F, Rai, Nirmala, Sharma, Pawana, Deeks, Jon, Berhane, Sarah, Mallett, Sue, Saha, Pratyusha, Solanki, Rita, Bayliss, Susan, Snell, Kym, Sundar, Sudha

    Published in Cancers (26-07-2022)
    “…Background: Ovarian cancer (OC) is a diagnostic challenge, with the majority diagnosed at late stages. Existing systematic reviews of diagnostic models either…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Glucagon-like peptide analogues for type 2 diabetes mellitus: systematic review and meta-analysis by Shyangdan, Deepson S, Royle, Pamela L, Clar, Christine, Sharma, Pawana, Waugh, Norman R

    Published in BMC endocrine disorders (09-12-2010)
    “…Glucagon-like peptide (GLP-1) analogues are a new class of drugs used in the treatment of type 2 diabetes. They are given by injection, and regulate glucose…”
    Get full text
    Journal Article
  12. 12

    Glucagon-like peptide analogues for type 2 diabetes mellitus by Shyangdan, Deepson S, Royle, Pamela, Clar, Christine, Sharma, Pawana, Waugh, Norman, Snaith, Alisa

    Published in Cochrane database of systematic reviews (05-10-2011)
    “…Glucagon-like peptide analogues are a new class of drugs used in the treatment of type 2 diabetes that mimic the endogenous hormone glucagon-like peptide 1…”
    Get more information
    Journal Article
  13. 13

    Models of care for chronic kidney disease: A systematic review by Nicoll, Ruairidh, Robertson, Lynn, Gemmell, Elliot, Sharma, Pawana, Black, Corri, Marks, Angharad

    Published in Nephrology (Carlton, Vic.) (01-05-2018)
    “…ABSTRACT Aim Chronic kidney disease (CKD) is common and presents an increasing burden to patients and health services. However, the optimal model of care for…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Screening for major diseases in community pharmacies: a systematic review by Ayorinde, Abimbola Adebukola, Porteous, Terry, Sharma, Pawana

    “…Objectives The aim of this systematic review was to assess the published evidence about the feasibility and acceptability of community pharmacy‐based screening…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Denosumab for treatment of bone metastases secondary to solid tumours: Systematic review and network meta-analysis by Ford, John A, Jones, Rob, Elders, Andrew, Mulatero, Clive, Royle, Pamela, Sharma, Pawana, Stewart, Fiona, Todd, Radha, Mowatt, Graham

    Published in European journal of cancer (1990) (01-01-2013)
    “…Abstract Aim To evaluate the evidence for denosumab for the treatment of bone metastases secondary to solid tumours and, using a network meta-analysis,…”
    Get full text
    Journal Article
  18. 18

    Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease by Sharma, Pawana, Blackburn, Rachel C, Parke, Claire L, McCullough, Keith, Marks, Angharad, Black, Corri

    Published in Cochrane database of systematic reviews (05-10-2011)
    “…Chronic kidney disease (CKD) is a long term condition that occurs as a result of damage to the kidneys. Early recognition of CKD is becoming increasingly…”
    Get more information
    Journal Article
  19. 19